产品: Galectin 1 抗体
货号: DF2383
描述: Rabbit polyclonal antibody to Galectin 1
应用: WB IHC IF/ICC
文献验证: IHC, IF/ICC
反应: Human, Mouse, Rat
预测: Bovine, Horse, Sheep, Dog
蛋白号: P09382
RRID: AB_2839591

浏览相似产品>>

   规格 价格 库存
 50ul RMB¥ 1250 现货
 100ul RMB¥ 2300 现货
 200ul RMB¥ 3000 现货

货期: 当天发货

联系销售

产品描述

来源:
Rabbit
应用:
WB 1:500-1:2000, IF/ICC 1:100-1:500, IHC 1:50-1:200
*The optimal dilutions should be determined by the end user. For optimal experimental results, antibody reuse is not recommended.
*Tips:

WB: 适用于变性蛋白样本的免疫印迹检测. IHC: 适用于组织样本的石蜡(IHC-p)或冰冻(IHC-f)切片样本的免疫组化/荧光检测. IF/ICC: 适用于细胞样本的荧光检测. ELISA(peptide): 适用于抗原肽的ELISA检测.

反应:
Human, Mouse, Rat
克隆:
Polyclonal
特异性:
Galectin 1 Antibody detects endogenous levels of total Galectin 1.
RRID:
AB_2839591
引用格式: Affinity Biosciences Cat# DF2383, RRID:AB_2839591.
偶联:
Unconjugated.
纯化:
The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin (Thermo Fisher Scientific).
保存:
Rabbit IgG in phosphate buffered saline, pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
别名:

展开/折叠

14 kDa laminin-binding protein; 14 kDa lectin; Beta galactoside binding lectin; Beta galactoside binding lectin L 14 I; beta galactoside binding protein; Beta-galactoside-binding lectin L-14-I; DKFZp686E23103; Gal 1; Gal-1; GAL1; Galaptin; Galbp; Galectin; Galectin-1; Galectin1; GBP; HBL; HLBP14; HPL; L 14.5; L-14.5; L14; Lactose binding lectin 1; Lactose-binding lectin 1; Lect14; Lectin galactoside binding soluble 1; Lectin galactoside-binding soluble 1; LEG1_HUMAN; LGALS 1; LGALS1; Lgals1 lectin galactose binding soluble 1; MAPK activating protein MP12; Putative MAPK activating protein MP12; Putative MAPK-activating protein PM12; S Lac lectin 1; S-Lac lectin 1;

抗原和靶标

免疫原:

A synthesized peptide derived from human Galectin 1, corresponding to a region within the internal amino acids.

基因/基因ID:

文献引用

1). Dihydroartemisinin inhibits galectin-1-induced ferroptosis resistance and peritoneal metastasis of gastric cancer via the Nrf2-HO-1 pathway. Phytomedicine : international journal of phytotherapy and phytopharmacology, 2025 (PubMed: 41166905) [IF=6.7]

Application: IHC    Species: human    Sample: GC tissues

Fig. 1. Galectin-1 plays a critical role in GCPM. (A) Representative images of H&E staining and galectin-1 IHC in GC tissues from patients with or without PM. (B) IRS scores of galectin-1 expression in GC tissues from patients with or without PM(n = 132). (C) Data from the GEPIA database showing the expression levels of LGALS1 in GC tissues compared with normal tissues. (D) The TIMER database illustrates LGALS1 expression in tumour and adjacent normal tissues. GEPIA data further indicate that LGALS1 expression correlates with the detailed clinical stage (E) and gross tumour stage (F) of GC. The Kaplan–Meier survival analysis demonstrates the associations between LGALS1 expression and the first-progression survival (G), postprogression survival (H), and overall survival (I) of GC patients. (J) A representative image showing the GCPM model using HGC-27 cells with different levels of galectin-1 expression. (K) Statistical analysis of the number of peritoneal metastatic nodules across the experimental groups. (L) H&E staining confirmed that the peritoneal nodules were adenocarcinoma tissue(400 × magnification). WT: Wild Type; NS: not statistically significant

Application: IF/ICC    Species: human    Sample: HGC-27 cells

Fig. 2. Galectin-1 increases the proliferation, invasion, and migration of GC cells. Representative images of PI/calcein staining in HGC-27 (A) and SGC-7901 (B) cell lines with varying levels of galectin-1 expression(200 × magnification). (C) Quantitative analysis of live cell proportions in all experimental groups by PI/calcein-AM staining. Representative images of EdU-stained HGC-27 (D) and SGC-7901 (E) cells with different galectin-1 expression levels(200 × magnification). (F) Quantification of EdU-positive cells in the various groups.(G)Representative images illustrating the migratory and invasive capacities of GC cells with altered galectin-1 expression(200 × magnification). (H) Statistical analyses of the number of migrated and invaded cells, respectively. (I)Representative images from colony formation assays performed in HGC-27 and SGC-7901 cells. (J) Quantitative results of colony-forming units for HGC-27 and SGC-7901 cells, respectively. WT: Wild Type; NS: not statistically significant

2). Establishment of papillary thyroid cancer organoid lines from clinical specimens. Frontiers in Endocrinology, 2023 (PubMed: 36992805) [IF=3.9]

Application: IF/ICC    Species: Mouse    Sample:

Figure 4 Immunofluorescence staining of CK19, Gal-1, Gal-3, and Ki-67 on PTC- and NTG-derived organoids and the matched tumor tissues. Nuclei were counterstained with DAPI (blue). Passage numbers of these organoid lines were: PTC-3_O, P3; PTC-10_O, P5; NTG-1_O, P4. CK19, Cytokeratin 19; Gal-1, Galectin-1; Gal-3, Galectin-3; NTG, nodular thyroid goiter; T, tumor; O, organoid. Scale bar, 100 µm.

限制条款

产品的规格、报价、验证数据请以官网为准,官网链接:www.affbiotech.com | www.affbiotech.cn(简体中文)| www.affbiotech.jp(日本語)

产品的数据信息为Affinity所有,未经授权不得收集Affinity官网数据或资料用于商业用途,对抄袭产品数据的行为我们将保留诉诸法律的权利。

产品相关数据会因产品批次、产品检测情况随时调整,如您已订购该产品,请以订购时随货说明书为准,否则请以官网内容为准,官网内容有改动时恕不另行通知。

Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时,请您在Affinity官方渠道提交售后申请。

产品仅供科学研究使用。不用于诊断和治疗。 

产品未经授权不得转售。

Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.